---
document_datetime: 2024-07-31 09:41:09
document_pages: 16
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/docetaxel-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: docetaxel-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 9.1510739
conversion_datetime: 2025-12-20 09:22:07.101864
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Docetaxel Accord

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0062               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 30/07/2024                          |                                             | PL                               |           |
| IA/0061              | A.7 - Administrative change - Deletion of manufacturing sites                                    | 12/07/2024                          | n/a                                         |                                  |           |

1 Notifications  are issued for  type I variations  and Article  61(3) notifications  (unless part of a group including a type II variation  or extension  application  or a worksharing  application).  Opinions are  issued for all  other procedures.

2 A Commission  decision  (CD) is issued for procedures  that affect  the terms of the marketing  authorisation  (e.g.  summary of  product characteristics,  annex  II, labelling,  package  leaflet).  The CD is issued within two  months of  the opinion  for variations  falling  under the scope of  Article  23.1a(a)  of Regulation  (EU) No.  712/2012, or within  one year  for other procedures.

3 SmPC  (Summary  of Product Characteristics),  Annex  II, Labelling,  PL (Package  Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0060   | B.III.1.a.5 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate of a non-sterile AS that is to be used in a sterile medicinal product, where water is used in the last steps of the synthesis and the material is not claimed   | 06/12/2023   | n/a        |             | to be endotoxin free   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|------------------------|
| IA/0059   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                       | 31/10/2023   | n/a        |             |                        |
| IA/0058   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                  | 12/09/2023   | n/a        |             |                        |
| IB/0057   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                      | 12/09/2023   | 22/02/2024 | SmPC and PL |                        |
| IB/0056   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                              | 17/08/2023   | n/a        |             |                        |
| IA/0055   | B.II.e.3.b - Change in test procedure for the immediate packaging of the finished product - Other changes to a test procedure (including replacement                                                                                                                                                              | 12/06/2023   | n/a        |             |                        |

<div style=\"page-break-after: always\"></div>

|             | or addition)                                                                                                                                                                                                                                                                                                                                                                                     |            |            |                 |               |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|---------------|
| IB/0054     | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                   | 09/03/2023 | 22/02/2024 | SmPC and PL     |               |
| IA/0053     | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                                 | 13/01/2023 | n/a        |                 |               |
| IA/0052     | B.III.1.a.4 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Deletion of certificates (in case multiple certificates exist per material)                                                                                                                                                                                    | 09/12/2022 | n/a        |                 |               |
| IA/0051     | B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information                                                                                                                                                                                                                   | 14/06/2022 | n/a        |                 |               |
| IA/0050     | A.7 - Administrative change - Deletion of sites                                                                                                                                                                                                                                                                                                                                                  | 16/12/2021 | 28/11/2022 | Annex II and PL | manufacturing |
| IAIN/0049/G | This was an application for a group of variations. B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate | 31/08/2021 | n/a        |                 |               |

<div style=\"page-break-after: always\"></div>

|           | from an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                                                      |            |            |             |         |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|---------|
| IB/0048   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                               | 12/10/2020 | 04/10/2021 | SmPC and PL |         |
| IB/0047   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by                                                                                                                                                                                       | 17/01/2020 | 21/02/2020 | SmPC and PL | the MAH |
| IA/0046   | B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier                                                                                                                                                                                                                                                                                                 | 09/12/2019 | n/a        |             |         |
| IA/0045/G | This was an application for a group of variations. B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer | 15/07/2019 | n/a        |             |         |

<div style=\"page-break-after: always\"></div>

| IB/0044     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                                                                                                                           | 23/05/2019   | 21/02/2020   | SmPC and PL   |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------|
| IAIN/0043/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 06/05/2019   | n/a          |               |
| IAIN/0042/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place | 05/03/2019   | n/a          |               |

<div style=\"page-break-after: always\"></div>

|             |                                                                                                                                                                                                                                                                                                       |            | 01/03/2019   | SmPC, Labelling and   |                                                                                                                                                                                                                                                                               |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|--------------|-----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0040/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer | 12/10/2018 | 01/03/2019   | Annex II and PL       |                                                                                                                                                                                                                                                                               |
| IB/0039/G   | responsible for importation and/or batch release - Not including batch control/testing This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a FP - Secondary packaging                                                                                          | 28/09/2018 | n/a          |                       | manufacturing site for the site B.II.b.1.b - Replacement or manufacturing site for the site B.II.b.1.f - Replacement or manufacturing site for part manufacturing process of the manufacturing operation(s) release, batch control, and sterile medicinal products (including |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |            |     |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IA/0037/G | This was an application for a group of variations. B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.4 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Deletion of certificates (in case multiple certificates exist per material) | 20/07/2018 | n/a |
| IB/0038   | B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 19/07/2018 | n/a |

<div style=\"page-break-after: always\"></div>

|           | relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |            |             |         |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|---------|
| IB/0036   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                         | 18/06/2018 | 02/07/2018 | SmPC and PL |         |
| IB/0035   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                         | 17/01/2018 | 02/07/2018 | SmPC and PL |         |
| IB/0034/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by | 21/12/2017 | 02/07/2018 | SmPC and PL | the MAH |

<div style=\"page-break-after: always\"></div>

| IA/0033   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                            | 29/11/2017   | n/a        |                                  |                                                                                                                                                                                                                                                                                |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0032   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                | 28/07/2017   | 02/07/2018 | SmPC and PL                      |                                                                                                                                                                                                                                                                                |
| R/0030    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                     | 15/12/2016   | 23/02/2017 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Docetaxel Accord in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IAIN/0031 | B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer                                                                                                                                     | 16/12/2016   | n/a        |                                  |                                                                                                                                                                                                                                                                                |
| IA/0029/G | This was an application for a group of variations. B.II.e.3.b - Change in test procedure for the immediate packaging of the finished product - Other changes to a test procedure (including replacement or addition) B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change | 19/05/2016   | n/a        |                                  |                                                                                                                                                                                                                                                                                |

<div style=\"page-break-after: always\"></div>

|           | the Ph. Eur. or national pharmacopoeia of a State                                                                                                                                                                                                            |            |            |                        | of Member   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------|
| II/0026   | B.II.b.4.d - Change in the batch size (including batch size ranges) of the finished product - The change relates to all other pharmaceutical forms manufactured by complex manufacturing processes                                                           | 10/03/2016 | n/a        |                        |             |
| IA/0028   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites manufacturer for batch release)                                                                        | 22/02/2016 | n/a        |                        | (excluding  |
| IB/0027   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 28/01/2016 | 27/01/2017 | SmPC, Labelling and PL |             |
| IAIN/0025 | B.III.1.a.3 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from a new manufacturer (replacement or addition)                                                          | 14/07/2015 | n/a        |                        |             |
| IA/0024   | B.III.1.a.4 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Deletion of certificates (in case multiple certificates exist per material)                                                | 29/05/2015 | n/a        |                        |             |
| IAIN/0023 | B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the                                                                                                                                                          | 13/05/2015 | n/a        |                        |             |

<div style=\"page-break-after: always\"></div>

|                    | relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer                                                                                                                                                                                                                                                           |            |            |      |                                   |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-----------------------------------|
| IB/0021/G          | This was an application for a group of variations. B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation B.II.b.4.z - Change in the batch size (including batch size ranges) of the finished product - Other variation                                                                   | 07/11/2014 | n/a        |      |                                   |
| PSUSA/1152/ 201311 | Periodic Safety Update EU Single assessment - docetaxel                                                                                                                                                                                                                                                                                       | 25/09/2014 | n/a        |      | PRAC Recommendation - maintenance |
| IB/0020            | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                  | 09/07/2014 | 03/07/2015 | SmPC |                                   |
| IB/0019/G          | This was an application for a group of variations. B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.III.2.a.1 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - AS | 12/05/2014 | n/a        |      |                                   |
| IAIN/0018          | B.III.1.a.3 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the                                                                                                                                                                                                                                           | 11/04/2014 | n/a        |      |                                   |

<div style=\"page-break-after: always\"></div>

|           | Ph. Eur. Monograph - New certificate from a manufacturer (replacement or addition)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |            |            |             | relevant new   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|----------------|
| IB/0015   | Update of section 4.4 and 4.5 of the SmPC in order to add a warning and update the safety information on interactions with CYP3A4 inhibitors further to the PRAC assessment of a signal. In addition, some inconsistencies have been rectified on the number and grade of alopecia adverse reactions in section 4.8 of the SmPC. Furthermore, the Product Information was brought in line with the latest QRD template version 9.0. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by | 19/03/2014 | 16/05/2014 | SmPC        | the MAH        |
| IA/0016   | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 07/03/2014 | n/a        |             |                |
| IB/0012/G | This was an application for a group of variations. To update section 4.4 to add warning on cystoid macular oedema based on the results of safety cumulative reviews conducted by the innovator's MAH and section 4.8 of the SmPC to include cystoid macular oedema and hyponatraemia in the list of                                                                                                                                                                                                                                                                                                                                                                                      | 20/11/2013 | 16/05/2014 | SmPC and PL |                |

<div style=\"page-break-after: always\"></div>

|           | adverse reactions following assessment by the CHMP for the originator product Taxotere. The Package Leaflet is updated accordingly. In addition the product information has been brought in line with the latest QRD version 9.0. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH   |            |     |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IAIN/0011 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 30/08/2013 | n/a |
| II/0007   | To add an alternative batch size of the finished product. B.II.b.4.d - Change in the batch size (including batch size ranges) of the finished product - The change relates to all other pharmaceutical forms manufactured by complex manufacturing processes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 27/06/2013 | n/a |

<div style=\"page-break-after: always\"></div>

| IB/0010   | Update of the SmPC for Docetaxel Accord following assessment of the same changes for the reference product, Taxotere. Sections 4.4 and 4.8 of the SPC are updated in order to add a warning related to respiratory disorders and to include interstitial pneumonitis, interstitial lung disease and pulmonary fibrosis as new adverse reactions observed the post- marketing setting following a relevant cumulative review of the originator product's safety database. The Package Leaflet is updated accordingly. Annex II was also updated according to QRD template version 8.3. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH   | 14/06/2013   | 16/05/2014   | SmPC, Annex II and PL   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------------------|
| IB/0009   | B.II.e.4.c - Change in shape or dimensions of the container or closure (immediate packaging) - Sterile medicinal products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 12/06/2013   | n/a          |                         |
| IB/0005/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 22/03/2013   | n/a          |                         |

<div style=\"page-break-after: always\"></div>

|           | batch control, and secondary packaging, for medicinal products (including those that are manufactured) excluding biological/ medicinal products                                                                                                                                                                                                                     |            |            |      | release, sterile aseptically immunological   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|----------------------------------------------|
| IB/0006/G | This was an application for a group of variations. B.II.b.3.z - Change in the manufacturing process of the finished product - Other variation B.II.b.3.z - Change in the manufacturing process of the finished product - Other variation B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation | 20/02/2013 | n/a        |      |                                              |
| IB/0008   | B.II.e.4.c - Change in shape or dimensions of the container or closure (immediate packaging) - Sterile medicinal products                                                                                                                                                                                                                                           | 11/02/2013 | n/a        |      |                                              |
|           | This was an application for a group of variations. B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.III.2.a.1 - Change of specification('s) of a former non Pharmacopoeial substance to comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - AS                               | 21/11/2012 | n/a        |      | IB/0003/G                                    |
| IB/0002   | To extend the shelf-life of the finished product from 15 to 24 months.                                                                                                                                                                                                                                                                                              | 18/09/2012 | 29/10/2012 | SmPC |                                              |

<div style=\"page-break-after: always\"></div>

|         | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)   |            |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------|------------|
| IB/0001 | B.II.b.4.z - Change in the batch size (including batch size ranges) of the finished product - Other variation                               | 22/08/2012 |